Arzu Didem Yalcin

Arzu Didem Yalcin

Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey

Biography
After completing his Internal Medicine residency, she completed his Allergy and Clinical Immunology residency at Akdeniz University between 2004-2009. He completed his compulsory service in Antalya Research and Training Hospital. Prof.Dr., who found the Omalizumab (Anti-IgE) molecule used in the treatment of Allergic Severe Asthma in the USA (Harvard University Biotechnology Department). She worked as Tse Wen Chang's medical consultant and project manager. It showed the TRAIL pathway for the first time in the world in terms of Severe Asthma and received the Outstanding Achievement Award from the World Allergy Association (WAO) in 2012